Serotype | Pre-vaccination | 1-month post-dose 2 | 1-year post-dose 2 | |||
---|---|---|---|---|---|---|
n = 95–131 | n = 89–118 | n = 55–73 | ||||
1 | 7 | (5.7–8.8) | 78 | (59.5–101.2) | 25 | (17.5–35.4) |
3 | 13 | (10.1–17.5) | 105 | (87.2–127.2) | 31 | (22.6–42.6) |
4 | 215 | (129.6–357.2) | 3051 | (2536.7–3670.3) | 1107 | (764.4–1602.2) |
5 | 10 | (7.8–13.9) | 273 | (213.9–349.2) | 102 | (70.5–148.0) |
6A | 246 | (149.0–404.8) | 7633 | (6439.6–9048.6) | 2485 | (1921.2–3214.3) |
6B | 626 | (377.5–1037.4) | 7601 | (6392.6–9038.6) | 3412 | (2746.4–4238.7) |
7F | 344 | (220.5–537.9) | 3723 | (3276.2–4230.1) | 2166 | (1861.4–2519.3) |
9V | 234 | (137.6–398.7) | 3467 | (2784.0–4317.6) | 1690 | (1157.8–2465.5) |
14 | 628 | (425.8–925.7) | 2081 | (1770.5–2446.0) | 1595 | (1281.6–1984.9) |
18C | 426 | (235.7–771.4) | 5271 | (4267.8–6510.1) | 1604 | (1107.2–2324.2) |
19A | 137 | (100.0–187.4) | 1314 | (1084.4–1592.6) | 589 | (449.4–771.1) |
19F | 94 | (55.0–160.7) | 1507 | (1139.9–1992.2) | 620 | (376.6–1020.4) |
23F | 34 | (21.5–54.8) | 2330 | (1880.4–2887.0) | 924 | (654.2–1306.1) |